These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2238073)

  • 1. Immunocytochemical investigations of vessel allograft arteriosclerosis using smooth muscle cell- and macrophage-specific monoclonal antibodies.
    Sasaguri S; Tsukada T; Hosoda Y
    Transplantation; 1990 Nov; 50(5):898-901. PubMed ID: 2238073
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunocytochemical investigations of cardiac and vessel allograft arteriosclerosis using smooth muscle cell and macrophage-specific monoclonal antibodies].
    Sasaguri S
    Nihon Geka Gakkai Zasshi; 1989 Nov; 90(11):1840-7. PubMed ID: 2608013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental studies on vein graft atherosclerosis (I). Histochemical studies using monoclonal antibodies for smooth muscle cells and macrophages.
    Numano F; Tsukada T; Amano J; Suzuki A
    Jpn Circ J; 1990 Nov; 54(11):1398-406. PubMed ID: 2287044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular cell adhesion molecule-1 up-regulation and phenotypic modulation of vascular smooth muscle cells predate mononuclear infiltration in transplant arteriopathy.
    Sai S; Iwata A; Thomas R; Allen MD
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):508-17. PubMed ID: 11547303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology of aortocoronary saphenous vein graft.
    Sundaram C; Ratnakar KS
    Indian Heart J; 1991; 43(2):123-4. PubMed ID: 1752615
    [No Abstract]   [Full Text] [Related]  

  • 6. Murine model of accelerated graft arteriosclerosis in primed recipients.
    Li S; Fu F; DeLeo J; Hoover J; Lake P; Shi V
    Transplant Proc; 2001; 33(1-2):405. PubMed ID: 11266884
    [No Abstract]   [Full Text] [Related]  

  • 7. A review of the histologic changes in vein-to-artery grafts, with particular reference to intimal hyperplasia.
    Dilley RJ; McGeachie JK; Prendergast FJ
    Arch Surg; 1988 Jun; 123(6):691-6. PubMed ID: 3285807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of graft arteriosclerosis in a rat carotid transplantation model.
    Zdoroveac A; Doebis C; Laube H; Brösel S; Schmitt-Knosalla I; Volk HD; Seifert M
    J Surg Res; 2008 Mar; 145(1):161-9. PubMed ID: 18164034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced transplant arteriosclerosis in plasminogen-deficient mice.
    Moons L; Shi C; Ploplis V; Plow E; Haber E; Collen D; Carmeliet P
    J Clin Invest; 1998 Nov; 102(10):1788-97. PubMed ID: 9819364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic basis of transplant-associated arteriosclerosis.
    Shi C; Lee WS; He Q; Zhang D; Fletcher DL; Newell JB; Haber E
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4051-6. PubMed ID: 8633015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcification of a polytetrafluoroethylene haemodialysis graft.
    Barendregt WB; van Knippenberg LA; Mravunac M
    Eur J Surg; 1993 Aug; 159(8):433-5. PubMed ID: 8218554
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of transplant coronary arteriosclerosis in rabbits by chronic estradiol treatment is associated with abolition of MHC class II antigen expression.
    Lou H; Kodama T; Zhao YJ; Maurice P; Wang YN; Katz N; Foegh ML
    Circulation; 1996 Dec; 94(12):3355-61. PubMed ID: 8989151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue response to an arterial substitute of bovine origin.
    Dillon ML; Scott SM; Vasquez MD; Postlethwait RW; Dart CH
    Arch Surg; 1972 Oct; 105(4):577-81. PubMed ID: 5071162
    [No Abstract]   [Full Text] [Related]  

  • 14. Atherosclerotic aneurysms of aortocoronary vein grafts.
    Liang BT; Antman EM; Taus R; Collins JJ; Schoen FJ
    Am J Cardiol; 1988 Jan; 61(1):185-8. PubMed ID: 3257347
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic rejection in rat aortic allografts. IV. Effect of hypercholesterolemia in allograft arteriosclerosis.
    Mennander A; Tikkanen MJ; Räisänen-Sokolowski A; Paavonen T; Ustinov J; Häyry P
    J Heart Lung Transplant; 1993; 12(1 Pt 1):123-31; discussion 131-2. PubMed ID: 8443189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flanking recipient vasculature, not circulating progenitor cells, contributes to endothelium and smooth muscle in murine allograft vasculopathy.
    Hagensen MK; Shim J; Falk E; Bentzon JF
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):808-13. PubMed ID: 21233450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor enhances cardiac allograft arteriosclerosis.
    Lemström KB; Krebs R; Nykänen AI; Tikkanen JM; Sihvola RK; Aaltola EM; Häyry PJ; Wood J; Alitalo K; Ylä-Herttuala S; Koskinen PK
    Circulation; 2002 May; 105(21):2524-30. PubMed ID: 12034660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of smooth-muscle cells and macrophages in cardiac allograft arteriosclerosis in rabbits.
    Sasaguri S; Eishi Y; Tsukada T; Sunamori M; Suzuki A; Numano F; Hatakeyama S; Hosoda Y
    J Heart Transplant; 1990; 9(1):18-24. PubMed ID: 2091615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic rejection--graft arteriosclerosis.
    Foegh ML
    Transplant Proc; 1990 Feb; 22(1):119-22. PubMed ID: 1968687
    [No Abstract]   [Full Text] [Related]  

  • 20. Intimal thickening of jugular and femoral veins vs arteries in the rabbit following investment.
    Funaki C; Naito M; Hayashi T; Kuzuya M; Asai K; Kuzuya F
    Angiology; 1990 Jul; 41(7):565-72. PubMed ID: 2389838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.